Related Experiment Video
Updated: Sep 27, 2025

Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
Published on: December 27, 2024
CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases
Jennifer Nhieu1, Yu-Lung Lin1, Li-Na Wei1
1Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.
Abstract:
In this review, we discuss the emerging role of Cellular Retinoic Acid Binding Protein 1 (CRABP1) as a mediator of non-canonical activities of retinoic acid (RA) and relevance to human diseases. We first discuss the role of CRABP1 in regulating MAPK activities and its implication in stem cell proliferation, cancers, adipocyte health, and neuro-immune regulation. We then discuss an additional role of CRABP1 in regulating CaMKII activities, and its implication in heart and motor neuron diseases. Through molecular and genetic studies of Crabp1 knockout (CKO) mouse and culture models, it is established that CRABP1 forms complexes with specific signaling molecules to function as RA-regulated signalsomes in a cell context-dependent manner. Gene expression data and CRABP1 gene single nucleotide polymorphisms (SNPs) of human cancer, neurodegeneration, and immune disease patients implicate the potential association of abnormality in CRABP1 with human diseases. Finally, therapeutic strategies for managing certain human diseases by targeting CRABP1 are discussed.
Insights
Cellular Retinoic Acid Binding Protein 1 (CRABP1) mediates non-canonical retinoic acid (RA) activities, impacting stem cells, cancer, and neurological disorders. Targeting CRABP1 offers therapeutic potential for various human diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cellular Retinoic Acid Binding Protein 1 (CRABP1) traditionally binds retinoic acid (RA).
- Emerging evidence suggests CRABP1 mediates non-canonical RA activities.
- These activities are relevant to various human diseases.
Purpose of the Study:
- To review the non-canonical roles of CRABP1.
- To explore CRABP1's involvement in regulating MAPK and CaMKII signaling pathways.
- To discuss the implications of CRABP1 in human diseases and potential therapeutic strategies.
Main Methods:
- Review of molecular and genetic studies, including Crabp1 knockout (CKO) mouse models.
- Analysis of cell culture models.
- Examination of gene expression data and CRABP1 gene single nucleotide polymorphisms (SNPs) in patient cohorts.
Main Results:
- CRABP1 regulates MAPK activities, influencing stem cell proliferation, cancers, adipocyte health, and neuro-immune regulation.
- CRABP1 also regulates CaMKII activities, impacting heart and motor neuron diseases.
- CRABP1 forms RA-regulated signalsomes in a cell context-dependent manner.
Conclusions:
- CRABP1 plays a significant role in diverse cellular processes beyond canonical RA signaling.
- Abnormalities in CRABP1 are implicated in human diseases like cancer, neurodegeneration, and immune disorders.
- Targeting CRABP1 presents a promising therapeutic avenue for managing these conditions.
More Related Videos
09:04Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
Published on: April 22, 2017
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Negative Regulator Molecules